Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial

Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:18:23.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces NIH website changes and says that some NIH content will use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with a link to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:19:21.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2, while the study page still displays a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-10-18T14:07:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T14:13:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a new revision tag (v3.7.0) and a large set of study-related terms and keywords were removed, indicating a restructuring of the trial's metadata and indexing.
    Difference
    17%
    Check dated 2026-09-20T20:16:21.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision changed from v3.6.5 to v3.6.6 on the page, indicating a newer build/version. No visible content changes are inferred from this update.
    Difference
    0.1%
    Check dated 2026-08-30T08:20:52.000Z thumbnail image

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.